Evaluation of serum antibody responses against the rotavirus nonstructural protein NSP4 in children after rhesus rotavirus tetravalent vaccination or natural infection

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 10, 2005, Pages 1157-1163

  Vizzi, Esmeralda ^a   Calviño, Eva ^a   González, Rosabel ^b   Pérez Schael, Irene ^b   Ciarlet, Max ^c,d   Kang, Gagandeep ^c,e   Estes, Mary K ^c   Liprandi, Ferdinando ^a   Ludert, Juan E ^a  

^a Instituto Venezolano de Investigaciones Cientificas Centro de Microbiologia y Biologia Celular   (Venezuela)

^b INSTITUTO DE BIOMEDICINA   (Venezuela)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; GLUTATHIONE TRANSFERASE; PROTEIN VP6; ROTAVIRUS NONSTRUCTURAL PROTEIN 4;

ADOLESCENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL ARTICLE; DIARRHEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MALE; PRIORITY JOURNAL; RECIPIENT; ROTAVIRUS; SEROCONVERSION; STRAIN DIFFERENCE; VACCINATION; VIRUS INFECTION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CASE-CONTROL STUDIES; DIARRHEA; DRUG EVALUATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; TOXINS, BIOLOGICAL; VIRAL NONSTRUCTURAL PROTEINS;

EID: 26944503032     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.10.1157-1163.2005     Document Type: Article

References (33)

1. Au, K.-S., W.-K. Chan, J. W. Burns, and M. K. Estes. 1989. Receptor activity of rotavirus nonstructural glycoprotein NS28. J. Virol. 63:4553-4562.
2. Ball, J. M., P. Tian, C. Q. Zeng, A. P. Morris, and M. K. Estes. 1996. Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science 272:101-104.
3. Bertolotti-Ciarlet, A., M. Ciarlet, S. E. Crawford, M. Conner, and M. K. Estes. 2003. Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice. Vaccine 21:3885-3900.
4. Boshuizen, J. A., J. H. J. Reimerink, A. M. Korteland-van Male, V. J. J. van Ham, M. P. G. Koopmans, H. A. Büller, J. Dekker, and A. W. C. Einerhand. 2003. Changes in small intestinal homeostasis, morphology, and gene expression during rotavirus infection of infant mice. J. Virol. 77:13005-13016.
5. Burns, J. W., M. Siadat-Pajouh, A. A. Krishnaney, and H. B. Greenberg. 1996. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 272:104-107.
6. Cheng, S. C., E. F. Fynan, H. L. Robinson, S. Lu, H. B. Greenberg, J. C. Santoro, and J. E. Herrmann. 1997. Protective immunity induced by rotavirus DNA vaccines. Vaccine 15:899-902.
7. Chiba, S., T. Yokoyama, S. Nakata, Y. Morita, T. Urasawa, K. Taniguchi, S. Urasawa, and T. Nakao. 1986. Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet ii:417-421.
8. Ciarlet, M., F. Liprandi, M. E. Conner, and M. K. Estes. 2000. Species specificity and interspecies relatedness of NSP4 genetic groups by comparative NSP4 sequence analyses of animal rotaviruses. Arch. Virol. 145:371-383.
9. Diepolder, H., R. Zachoval, R. Hoffman, E. Wierenga, T. Santantonio, M.-C. Jung, D. Eichenlaub, and G. Pape. 1995. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006-1007.
10. Feng, N., P. T. Vo, D. Chung, T. P. Vo, Y. Hoshino, and H. B. Greenberg. 1997. Heterotypic protection following oral immunization with live heterologous rotavirus in a mouse model. J. Infect. Dis. 175:330-341.
11. Flores, J., I. Perez-Schael, M. Blanco, A. M. Rojas, E. Alfonzo, I. Crespo, W. Cunto, A. L. Pittman, and A. Z. Kapikian. 1993. Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine. J. Clin. Microbiol. 31:2439-2445.
12. Hall, R., T. Brand, M. Lobigs, M. Y. Sangster, and M. Howard. 1996. Protective immune responses to the E and NS1 proteins of Murray Valley encephalitis virus in hybrids of flavivirus-resistant mice. J. Gen. Virol. 77:1287-1294.
13. Hjelt, K., P. C. Grauballe, A. Paerregard, O. H. Nielsen, and P. A. Krasilnikoff. 1987. Protective effect of preexisting rotavirus specific immunoglobulin A against naturally acquired rotavirus infection in children. J. Med. Virol. 21:39-47.
14. Ishida, S.-I., N. Feng, B. Tang, J. M. Gilbert, and H. B. Greenberg. 1996. Quantification of systemic and local immune responses to individual rotavirus proteins during rotavirus infection in mice. J. Clin. Microbiol. 34:1694-1700.
15. Ishida, S. I., N. Feng, J. M. Gilbert, B. Tang, and H. B. Greenberg. 1997. Immune responses to individual rotavirus proteins following heterologous and homologous rotavirus infection in mice. J. Infect. Dis. 175:1317-1323.
16. Jiang, B., J. R. Gentsch, and R. I. Glass. 2002. The role of serum antibodies in the protection against rotavirus disease: an overview. Clin. Infect. Dis. 34:1351-1361.
17. Johansen, K., J. Hinkula, F. Espinoza, M. Levi, C. Zeng, U. Ruden, T. Vesikari, M. Estes, and L. Svensson. 1999. Humoral and cell-mediated immune responses in humans to the NSP4 enterotoxin of rotavirus. J. Med. Virol. 59:369-377.
18. Kapikian, A. Z., R. J. Yolken, and H. B. Greenberg. 1979. Gastroenteritis viruses, p. 927-995. In E. H. Lennette and N. J. Schmidt (ed.), Diagnostic procedures for viral, rickettsial, and chlamydial infections, 5th ed. American Public Health Association, Washington, D.C.
19. Liprandi, F., B. Brito, L. Palencia, and J. Esparza. 1986. Derivation of a monoclonal antibody against the group specific antigen of rotaviruses and its use in a diagnostic enzymatic immunoassay. Acta Cient. Venez. 37:432-436.
20. Mori, Y., M. A. Borgan, N. Ito, M. Sugiyama, and N. Minamoto. 2002. Sequential analysis of nonstiuctural protein NSP4s derived from group A avian rotaviruses. Virus Res. 89:145-151.
21. Murray, A. M., C. D. Kelly, S. S. Nussey, and A. P. Johnstone. 1998. Production of glutathione-coated microtitre plates for capturing recombinant glutathione S-transferase fusion proteins as antigens in immunoassays. J. Immunol. Methods 218:133-139.
22. O'Neal, C. M., S. E. Crawford, M. K. Estes, and M. E. Conner. 1997. Rotavirus virus-like particles administered mucosally induce protective immunity. J. Virol. 71:8707-8717.
23. O'Ryan, M. L., D. O. Matson, M. K. Estes, and L. K. Pickering. 1994. Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections. J. Infect. Dis. 169:504-511.
24. Petrie, B. L., H. B. Greenberg, D. Y. Graham, and M. K. Estes. 1984. Ultrastructural localization of rotavirus antigens using colloidal gold. Virus Res. 1:133-152.
25. Ray, P., J. Malik, R. K. Singh, S. Bhatnagar, R. Bahl, R. Kumar, and M. K. Bhan. 2003. Rotavirus nonstructural protein NSP4 induces heterotypic antibody responses during natural infection in children. J. Infect. Dis. 187:1786-1793.
26. Richardsson, S. C., K. Grimwood, and R. Bishop. 1993. Analysis of homotypic and heterotypic serum immune responses to rotavirus proteins following primary rotavirus infection by using the radioimmunoprecipitation technique. J. Clin. Microbiol. 31:377-385.
27. Salinas, B., G. González, R. González, M. Escalona, M. Materan, and I. Pérez-Schael. 2004. Epidemiologic and clinical characteristics of rotavirus disease during five years of surveillance in Venezuela. Pediatr. Infect. Dis. J. 23(Suppl. 10):S161-S167.
28. Tian, P., Y. Hu, W. P. Schilling, D. A. Lindsay, J. Eiden, and M. K. Estes. 1994. The nonstructural glycoprotein of rotavirus affects intracellular calcium levels. J. Virol. 68:251-257.
29. Vesikari, T., E. Isolauri, A. Delem, E. D'Hondt, F. E. Andre, and G. Zissis. 1983. Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children. Lancet 11:807-811.
30. Ward, R. L., M. N. McNeal, and J. F. Sheridan. 1992. Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody. Virology 188:57-66.
31. Ward, R. L. 2003. Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model. Viral Immunol. 16:17-24.
32. Yuan, L., S. Honma, S. Ishida, X. Y. Yan, A. Z. Kapikian, and Y. Hoshino. 2004. Species-specific but not genotype-specific primary and secondary isotype-specific NSP4 antibody responses in gnotobiotic calves and piglets infected with homologous host bovine (NSP4[A]) or porcine (NSP4[B]) rotavirus. Virology 330:92-104.
33. Yuan, L., S. Ishida, S. Honma, J. T. Patton, D. C. Hodgins, A. Z. Kapikian, and Y. Hoshino. 2004. Homotypic and heterotypic serum isotype-specific antibody responses to rotavirus nonstructural protein 4 and viral protein (VP) 4, VP6, and VP7 in infants who received selected live oral rotavirus vaccines. J. Infect. Dis. 189:1833-1845.